Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Phase III Trial to Investigate the Efficacy and Safety of an Orodispersible Tablet Vardenafil Versus Placebo in the Treatment of Men With Erectile Dysfunction (ED) - a Fixed-dose, Double-blind, Randomized Multi-center Trial - POTENT I

NCT00631969 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00631969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00631969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Phase III Trial to Investigate the Efficacy and Safety of an Orodispersible Tablet Vardenafil Versus Placebo in the Treatment of Men With Erectile Dysfunction (ED) - a Fixed-dose, Double-blind, Randomized Multi-center Trial - POTENT I
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2008
Completion date
January 31, 2009
Enrollment
362 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction